StonvexLoading…
StonvexStonvexStonvexCore line items from RSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $370.36M | $1.13B | $809.53M | $531.62M |
Operating Income | $42.78M | $87.42M | $58.71M | $39.25M |
Net Income | $9.07M | $33.31M | $28.06M | $22.01M |
EPS (Diluted) | $0.08 | $0.31 | $0.23 | $0.17 |
Total Assets | $677.28M | $658.51M | $593.16M | $543.02M |
Total Liabilities | $358.73M | $355.02M | $318.80M | $290.78M |
Cash & Equivalents | $330.56M | $336.26M | $273.50M | $240.59M |
Free Cash Flow OCF − CapEx | $19.86M | $164.24M | $95.33M | $54.14M |
Shares Outstanding | 106.85M | 236.12M | 234.96M | 234.41M |